🍽🦠 PubMed Studies Citing Bacteria Shifts for Lacticaseibacillus casei {L. casei} - Clostridioides difficile DA00145

Citations are updated once a week. Recently added citations may not appear.

4 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
📓 - Direct Citation   |   👪 - Infer Parent  |   👶 - Infer Child |   ⚗️ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😢 - Shifts in wrong direction
Context Citation
Lacticaseibacillus casei {L. casei} - Clostridioides difficile DA00145    👶 Lacticaseibacillus casei Strain T21 Attenuates Clostridioides difficile Infection in a Murine Model Through Reduction of Inflammation and Gut Dysbiosis With Decreased Toxin Lethality and Enhanced Mucin Production.
Frontiers in microbiology (Front Microbiol ) Vol: 12 Issue Pages: 745299
Pub: 2021 Epub: 2021 Dec 1 Authors Panpetch W , Phuengmaung P , Cheibchalard T , Somboonna N , Leelahavanichkul A , Tumwasorn S ,
Html Article Publication
Lacticaseibacillus casei {L. casei} - Clostridioides difficile DA00145    👶 Lactobacillus casei Zhang exerts probiotic effects to antibiotic-treated rats.
Computational and structural biotechnology journal (Comput Struct Biotechnol J ) Vol: 19 Issue Pages: 5888-5897
Pub: 2021 Epub: 2021 Oct 22 Authors Yao G , Cao C , Zhang M , Kwok LY , Zhang H , Zhang W ,
Html Article Publication
Lacticaseibacillus casei {L. casei} - Clostridioides difficile DA00145    👶 Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile.
Nutrients (Nutrients ) Vol: 10 Issue 5 Pages:
Pub: 2018 Apr 26 Epub: 2018 Apr 26 Authors Alberda C , Marcushamer S , Hewer T , Journault N , Kutsogiannis D ,
Html Article Publication
Lacticaseibacillus casei {L. casei} - Clostridioides difficile DA00145    👶 Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review.
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 4 Issue 2 Pages: 160-78
Pub: 2015 Apr 13 Epub: 2015 Apr 13 Authors McFarland LV ,
Html Article Publication

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)